Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 1 Study to Investigate the Safety, Tolerability and Pharmacokinetics of Single-Ascending Doses of FBL-MTX in Healthy Subjects

NCT05117593 is registered in ClinicalTrials.gov with SOLFARCOS - Pharmaceutical and Cosmetic Solutions Ltd as lead sponsor.

NCT NCT05117593
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05117593 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 1 Study to Investigate the Safety, Tolerability and Pharmacokinetics of Single-Ascending Doses of FBL-MTX in Healthy Subjects
Lead sponsor
SOLFARCOS - Pharmaceutical and Cosmetic Solutions Ltd
Phase
Phase 1
Overall status
Completed
Start date
June 28, 2021
Completion date
October 19, 2021
Enrollment
32 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

rheumatoid arthritis